Xcell Biosciences announced today the company has closed a $12 million Series A private equity financing round. The financing was led by HBM Genomics along with the continued participation of all ...
CARLSBAD, Calif. & KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, today announced it has reached ...
SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and ...